Susan G. Komen for the Cure, the breast cancer “Race for the Cure” organizer, that famously dumped Planned Parenthood as a grant recipient last year in response to religious right and House GOP objections, gave its then- (and possibly still) CEO Nancy Brinker a whopping 64% raise last year.
Brinker’s annual salary went from $417,000 to $684,717.
It’s ironic that in a year in which Nancy Goodman Brinker, a major GOP donor who served as an ambassador in the Bush administration, nearly destroyed the Komen brand by making it political (and far-right political, at that), Brinker’s not rewarded with a pink slip, but rather with a big fat pink check.
Brinker claimed last August, following the Planned Parenthood fiasco, that she would soon be stepping down as CEO of Komen for the Cure. But according to the Dallas Morning News, she remains the CEO according to the Komen Web site. And they’re right – I just checked:
A man who lost his wife and sister-in-law to breast cancer was unimpressed with Brinker’s raise:
These salaries may be legal, but in my opinion they’re immoral. People like Nancy Brinker are opportunists who see charity as a means to a lucrative payday.
I had hoped the kerfuffle over Planned Parenthood would wake up the organization on which so many of us have pinned our hopes for a cure. It appears that Brinker and others of her ilk are immune to public shame.
He’ll be even less impressed when he finds out that, according to Mary Elizabeth Williams of Salon, Komen spent just 15% of its donations on research in 2011, “nearly half of what it did just a few years prior,” says Williams. Williams adds:
Even after so much disaster, it seems the woman who’s benefited most from Komen’s charity is still Nancy Brinker herself.
I never believed Komen’s weak-tea apology last year, and warned at the time that people shouldn’t believe it. I still think women’ advocates gave in to Komen far too quickly and far too easily. And judging by Brinker’s raise, and the fact that more than a year after the Planned Parenthood snafu Brinker remains CEO, after she promised to step down, suggests that it’s sadly business-as-usual at the Race for the Cure.